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Summary
To characterize the function of the CD3r1 subunit of the T cell receptor (TCR), we have used
cDNAs encoding CD3', CD3r1, or both to reconstitute a variant o£ a cytochrome c-specific,
I-Ek-restricted murine T cell hybridoma, termed MA5.8, which lacks CD3' and CD3r1 proteins.
We provide direct evidence that assembly and surface expression ofTCRs can be mediated by
either of these subunits separately or together. However, the level of TCR expression on ~
transfectants is up to one order of magnitude greater than that on 'q transfectants, implying
that CD3r1 is weakly associated with the pentameric Tia-0CD3y6e complex and/or inefficient
at salvaging the incomplete TCR from lysosomal degradation . As a component of the TCR,
the CD3q subunit preferentially forms a heterodimer with C133', but is also able to form a
C133r1-tl homodimer. Crosslinking ofTia-#CD3y6er P, Tia-0CD3y6er1-rl, or Tia-0CD3-y&r
r/rr1 TCR isotypes with anti-CD3e monoclonal antibody or a rytochrome c peptide epitope
on I-Ek antigen-presenting cells mediates signal transduction resulting in reversible cell-cycle
arrest of transfected clones . Given the potential for diversity ofsignals generated by these functional
TCR isotypes and the expression of the CD3 r1 gene product in the thymus, CD3r1 is likely
to play a role in selection and/or activation of thymocytes during development .
T
he TCR, a molecular complex consisting of at least seven
subunits, is responsible for recognition of foreign an-
tigen in the context of a particularMHC product (reviewed
in references 1-4). The clonally unique antigen-specific binding
component of this receptor has been termed Ti and exists
as a disulfide-linked ct-,8 heterodimer on the majority of pe-
ripheral T cells. The subunits of Ti are Ig-like and are com-
posed ofvariable and constant regions. In turn, the Ti struc-
ture is noncovalently associated with a set of invariant
molecules referred to as the CD3 subunits. CD3y, CD3S,
and CD3e are structurally related polypeptides encoded by
closely linked genes located on human chromosome 11 and
mousechromosome 9 (5-8) . In contrast, the structurally dis-
tinct CD3' molecule is encoded on chromosome 1 in both
man and mouse (9, 10) . CD3y, CD3b, andCD3e exist pri-
marily as monomeric components in the TCR, although a
minor component ofCD3e disulfide-linked homodimers has
been found inhuman and murine TCRs (10a) . CD3ris found
primarily as a homodimer within the CD3Ti complex (11) .
Recent work has suggested an additional level ofcomplexity
ofTCR structure in that -10% of CD3r subunits exist as
disulfide-linked heterodimers, bonded to another subunit,
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termed CD3q (11) . It is particularly interesting that studies
have suggested that although the copy number of the TCR-
associated C133--q heterodimer is one order of magnitude
less than that ofCD3P~ homodimers, CD3y r1 may be im-
portant in coupling theTCR to phosphoinositide hydrolysis
(12) . Furthermore, other studies using murine T-T hybrid-
omas have suggested thatCD3y,qmay be important in TCR-
mediated programmed cell death (13) .
Given the potential importance of the CD3r1 subunit of
the TCR, we recently characterized the primary structure
of murine CD3r1 as deduced from protein microsequencing
and cDNA cloning (14) . The mature CD3q protein was
predicted to consist of a 9 amino acid extracellular segment,
a 21 amino acid transmembrane segment harboring a nega-
tively charged residue characteristic of C133 subunits, and
a 155 amino acid cytoplasmic tail. The NH2-terminal se-
quences of CD3r1 and CD3' were found to be identical
through the first 122 amino acids of each mature protein and
to diverge in their COOH-terminal regions . These findings
were consistent with the possibility that CD3q and CD3r
were alternatively spliced products of acommon gene . This
supposition has been verified by direct genomic cloning and
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Hussey, S. Kuyasu, andE.L. Reinherz, manuscript submitted
for publication) . This differential splicing results in a cyto-
plasmic domain of CD3q which is 42 amino acids longer
than that ofCD3~ In addition, CD3r1 lacks oneofsix poten-
tial tyrosine phosphorylation sites and, perhaps more impor-
tantly, aputative nucleotide binding site previously identified
in CD3f (15) .
To directly analyze the consequences of these structural
differences in CD39 and CD3~, we have used transfection
techniques to express CD3r1 andCD3~ cDNAs in eukary-
otic expression vectors separately or together in murine T
cells lacking CD3q and CD3~ proteins. The results to be
reported below demonstrate for the first time that the CD3r1
subunit in the form of a CD3r1-rl homodimer is able to as-
sociate with and transport Tia-/6CD3y6E pentamers to the
cell surface. Thus,TCRassembly, surface expression andfunc-
tion are not restricted to the CD3t~ homodimer or the
CD3~--r1 heterodimer. Substantial differences in TCR copy
number resulting fromCD3r1 vs.CD3fcDNA transfection
using the same expression vectors suggest that CD3r1 and
CD3~ isoforms may differentially regulate surfaceTCR ex-
pression . In addition, functional studies with transfectants
expressing Tia-,13CD3y6Er, f, Tia-RCD3y6Er1-q, and Tiu-
OCD3ySEr~/~-rl indicate that each TCRisoform is compe-
tent to mediatesignal transfuction . Theimplications ofthese
findings for differential TCR triggering during thymic on-
togeny are discussed .
Materials and Methods
BALB/c mice andB10.BRmice were purchasedfrom TheJackson
Laboratory (Bar Harbor, ME) or Taconic Farms (German Town,
NY). New Zealand white rabbits were from Pine Acres Rabbitwy
(Brattleboro, VT). RPMI 1640 medium, L-glutamine, penicillin-
streptomycin, and G418 (geneticin) were purchased from Gibco
Laboratories (Grand Island, NY) . FCS andpropidium iodide were
from SigmaChemicalCo . (St . Louis, MO). FITC-conjugatedIgG
fraction ofgoat antiserum againstmouseIgG wasfrom Whittaker
M.A . Bioproducts (Walkersville, MD). FITC-conjugatedIgG fiac-
tion of goat antiserum against hamster IgG that does not cross-
reactwith mouseIgGwasfrom Caltag Laboratories (So . San Fran-
cisco, CA) . Alkaline phosphatase-conjugated IgG fraction of goat
antiserum against rabbit IgG and prestained molecular weight
markers were from Biorad Laboratories (Richmond, CA) . RNase
A was from Worthington Biochemical Corp . (Freehold, NJ) .
Succinimydyl-4-6 maleimidophenyl butyrate (S-SMPB) was from
Pierce Chemical Co . (Rockford, IL) . Immulon plates (96-well,
round-bottomed ELISA plates) were from Dynatech Laboratories
(Chantilly, VA) . Polyvinyldifluoride (PVDF)t membrane was from
MilliporeCorp. (Bedford,MA). Nitrocellulose membrane was from
Schleicher&Schnell (Keene,NH).RPMI 1640 medium was gener-
ally supplemented with 50 U/ml penicillin G, 50 ttg/ml strep-
tomycin, and 4 MM L-glutamine.
A hamster-mouse somaticB cell hybridoma 145.201 producing
amAb (2C11) against murine CD3E (16), was generously provided
by J.A . Bluestone (National Institutes of Health, Bethesda, MD).
2C11mAb was purified from culture supernatant ofthe hybridoma.
1 Abbreviations used in this paper: PVDF, polyvinyldifluoride; 2-D, two-
dimensional.
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Anti-human Ti mAb 11C5 (IgG1) specific for an irrelevant TCR
clonotype used as a control antibody was made in our lab . mAb
A2B4.2 specific for the ot chain of the 2B4.11TCR (17) was the
generous gift ofJ . Ashwell (National Institutes of Health). Asyn-
thetic cytochrome c epitope corresponding to the residues 86-103
ofmoth cytochromecand lacking the residues 90-92 (18) was syn-
thesized on an automated peptide synthesizer (model 431A; Ap-
plied Biosystems Inc., Foster City, CA) and purified by reverse-
phase HPLC using a C18 column . The sequence of the peptide
is as follows: KKANDLIAYLKQATK .
Cells and Growth Conditions.
￿
The cytochrome c-specific, I-Et-
restricted murineT cell hybridoma 2114.11, its variantMA5.8 (19),
andthe antigen-presenting B cell hybridomaLK35.2 were generous
gifts ofJ . Ashwell (National Institutes ofHealth) . An ovalbumin-
specific, IAd-restricted murine T cell hybridoma 3DO54.8 was a
kind gift ofP . Marrack (NationalJewish Hospital, Denver, CO) .
Cellswere maintained inRPMI 1640 supplementedwith10%FCS .
Transfectantswere maintained inRPMI 1640 containing 10% FCS
and 500ttg/ml G418 . For determination of cell growth.afterTCR
crosslinking, T cell hybridomas and transfectants were plated into
96-well, round-bottomed Immulon plates with or without 201
mAb(4 ug/well) andcultured in RPMI 1640 containing 10% (vol/vol)
FCS at 2 x 104 cells/200 pl/well. Cell numbers were counted in
duplicate sampleson days 1, 2, and3 . To examinewhethergrowth
arrest afterCD3crosslinking is reversible, cells were collected from
the wells coated with201on day 1, replated into nontreated wells,
and cell numbers were counted on days 2 and 3.
Construction ofExpression Plasmids.
￿
The inserts of pBS17 (mu-
rine CD3r1) and pBS23 (murine CD3?) (14) were excised with
EcoRI and bluntedwithDNAPoll (Boehringer Mannheim Bio-
chemicals, Indianapolis, IN) . The inserts were ligated to pPink-2
(20) whichhadbeen cutwith Xbal andblunted as described above.
Ligationswere transformed into HB101and positive colonies were
identified by colony hybridization with CD3~- or CD377-specific
probes prepared by digesting pBS23 with EcoNI and EcoRl and
pBS17 with AvaII and EcoRl, respectively. The 3' fragments of
the cDNAs (14), were isolated in low melting agarose gels and
specific probes were labeled by the random-priming method (21).
PlasmidDNA was isolated from correct orientation constructs of
pPink-2/rand pPink-2/i7 by double banding in CsCl orby Qiagen
plasmid kits (Studio City,CA)followingthe manufacturer's recom-
mendations . PlasmidDNAwasprepared for transfection by linear-
ization with Xmnl . All restriction enzymeswere from New En-
gland Biolabs (Beverly, MA).
Generation and Flow Cyto'luorometric Analysis of Transfectants.
Transfections intoMA5.8 cellswere performedon a Bethesda Re-
search Laboratories (Gaithersburg, MD)Cell-Porator using200V
and a capacitance of 800AR 15 Kg pPink-2/~, pPink-2/7t, or both
were transfected . After transfecann, cells were plated in 6-well plates
in RPMI 1640 containing 10% FCS, at a concentration of 2 x
101 cells/2 ml/well. After 24 h, G418 was added at 1 mg/ml and
medium was changed every 2-3 d . G418-resistant clones were
selected over 2-3 wk and subcloning was carried out by limiting
dilution method at0.3 cells/well . Clones of transfectants are desig-
natedby the original number ofthe transfectant followed by a dec-
imal point and an additional number, i.e ., MAri61 .9 is a clone of
MArl61. Cell surfaceTCRexpression oftransfectants was quantified
by indirect immunofluorescence using 2C11(anti-CD3E)and 11C5
(control) antibodies and FITC-conjugated goat anti-hamster an-
tibody.
RNAAnalysis.
￿
TotalRNAwas isolated from 2B4.11, MA5.8,
and transfectants using guanidine isothiocyanate (22) .RNA con-
centrations were measured spectrophotometrically and 10 iag oftotalRNAwas runper lane on a 1% agarose gel containing 2.2M
formaldehyde and 1x MOPS buffer solution (22) . The RNA
was transferred to nitrocellulose in 20x SSC and theRNA blot
was hybridized to the CD3ri-specific probe described above. Hy-
bridization was in 50% formamide, 5x SSC, 5x Denhardt's,0.1%
SDS, 250 wg/ml denatured salmon sperm DNA, 50 mM NaP04,
pH 6.5, at 42°C for 16-20 h with 1 x 106 cpm/ml probe . After
washing in 2x SSC, 0.1% SDS for 15-30 min at room tempera-
ture and 0.1x SSC, 0.1% SDS at 50°C for 30 min, the blot was
exposed to KodakX-Omat AR x-ray film at -70°C for the indi-
cated times . The blot was then strippedby boiling in distilled water
for 10 min and exposed for 12-14 h to insure all signals had been
removed . The filter was next hybridized to theCD3especific probe
using conditions as described for theCD3-q specific probe, washed,
and autoradiographed .
1211 Surface Labeling, Immunoprecipitation, and Two-Dimensional
(2-D) Reducing/Nonreducing SDS-PAGE Analysis. 5 x 101 cells
were labeled with 1 mCi of 1211 by lactoperoxidase-catalyzed surface
iodination . They were then lysed in 1 ml of digitonin lysis buffer
solution (1% digitonin, 150mM NaCl, 1mM PMSF, 10 Wg/ml
aprotinin, 10mM iodoacetamide, 20mM Tris/HCI, pH 7.4) . After
2 h at 4°C, the lysates were centrifuged at 13,000 g for 15 min
at 4°C. The postnuclear supernatant was immunoprecipitated over-
night at 4°C with 25 Al of Sepharose beads coupled with 2C11
(3-5 mg/ml) . Thereafter, thepelleted beadswere washed once with
0.05% digitonin, 150mM NaCl,20mm Tris/HCI,pH 7.4, twice
with 150mM NaCl, 20 mM Tris/HCl, pH 7.4 (TBS), and once
with 20 mM Tris/HCI, pH 7.4 . The proteinwas eluted from the
beadsbyboiling for 5 min in 25 F,1 ofLaemmli's nonreducing SDS
sample buffer solution (23) . Samples were subject to electropho-
resis in 12.5% polyacrylamide using the nonreducing buffer system
ofLaemmli . The gelwas then equilibrated with reducing Laemmli's
SDS sample buffer solution for 20 min before the second dimen-
sion electrophoresis in a 12.5% polyacrylamide gel. The gels were
dried and autoradiographed with Kodak X-Omat AR x-ray film
at -70°C for 1-3 d .
Hetervantiserum Production.
￿
Arabbit polyclonal antiserum, NS-2,
was produced against a CD3vi-related peptide, CLWSPWPPS-
SSSQL, comprising theCOOH-terminal 13 amino acids of CD3ri
with an NH 2-terminal cysteine residue added for coupling pur-
poses . The peptide was synthesized with a peptide synthesizer
(model 431A ; AppliedBiosystems), cleaved from resin in trifluoroa-
cetic acid, and purified on a Waters Binary Gradient HPLC using
an RCM h Bondapak C18 25 x 100mm column. The peptide
was coupled to BSA pretreated with S-SMPB and 200 Ag of the
BSA-peptide conjugate in CFA (diluted 1:1 with PBS) injected in-
tradermally into -20 sites in the backs oftwo NewZealand white
rabbits . At 2wk, the rabbits were boostedwith 100Ag BSA-peptide
conjugate in IFA. Beginning at 4 wk, the rabbitswere bled weekly
from ear veins and the serum used in Western blot analysis.
Western Blotting.
￿
2-D SDS-PAGE of2C11 immunoprecipitates
was performed as described above. 1 x 108 cells were used in each
Western blot . Immediately after the 2nd dimension SDS-PAGE,
electrophoresic transfer to aPVDF membrane was carried out es-
sentially according to Legendre and Matsudaira (24) with a buffer
solution consisting of 25 mM Tris, 192mM glycine, 20% meth-
anol in a trans-blot apparatus (Bio-Rad Laboratories) following the
manufacturer's directions . ThePVDF membrane wasremoved from
the transblot, preincubated in TBS, containing 1% BSA for 2 h
at room temperature and then incubated with anti-77 antiserum
NS-2 (1:200 dilution) in TBS containing 1% BSA with gentle
shaking overnight . After three 15-min washes in TBS, containing
0.1% Triton X-100, the PVDF membrane wasincubated with alka-
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line phosphatase-conjugated goat anti-rabbit antibody (1:2,000 di-
lution) in TBS for 2 h. After three 15-min washes in TBS con-
taining 0.1% Triton X-100 and two 15-min washes in TBS, the
color was developed using Biorad alkaline phosphatase color de-
veloping kit following the manufacturer's instructions . After elec-
trophoretic transfer, all experiments were performed at room tem-
perature .
Activation ofTCells with Anti-CD3e mAbor Antigenpulsed Pre-
senting Cells. For the cell stimulation by crosslinking with anti-
body-coated plates, we cultured 2 x 104 cells/200 Al in triplicate
in 96-well Immulon plates. The wells were pretoated for at least
2 h at room temperature with 2C11 (4 Rg/well) or media. The
plates were washed twice with PBS . After 24 h of incubation the
cells were plated with 1 i.1,Ci/well ['H]TdR for 4 h and incorpo-
ration was measured by scintillation counting . For stimulation of
the cells with peptide antigen, 5 x 10 4 LK35.2 cells irradiated
with 10,000 rad were pulsed in 100 Al of media containing 1-100
AM moth cytochrome c peptide for 2 h in triplicate in 96-well,
round-bottomed microtiter plates. Subsequently 5 x 104 transfec-
tants in 100 pl of media were added to each well. After 24 h of
cultivation, DNA synthesis was determined by ['H]TdR incorpo-
ration as above.
Cell Cycle Analysis.
￿
Cells (2 x 10 5) were cultured for 24 h in
10 wells ofImmulon plates with or without 2C11 mAb, collected,
andwashed once withRPMI 1640 containing 10% (vol/vol) FCS .
After centrifugation, cell pelletswere mixedwith 0.5 ml ofa solu-
tion consisting of 50 Fog/ml propidium iodide, 0.05% NP40, 10
Etg/ml RNase A, and 0.1% sodium citrate. After incubation for
1 hr on ice, flow cytometrywasperformedusing aFACScan (Becton
Dickinson, Mountain View, CA) and the results were analyzed
by Dean's method (25) .
Results
Production ofCD3P il and ,' + r1 Transfectants.
￿
To directly
examine the role of CD317 in TCR assembly, surface expres-
sion, and signal transduction, CD3~ andCD3rlcDNAswere
cloned into the eukaryotic expression vector pPink-2 (20) by
standard methodology. In this vector (Fig . 1), expression of
the cDNA insert is under the control of the spleen focus
forming virus (SFFV) long terminal repeat (LTR) and the
presence of the neomycin resistance gene provides the selec-
tion marker for the antibiotic G418 . As shownin Fig . 1, CD3~
and CD3vl inserts are identical from nucleotide 50 to 568
beingderived from the same gene locus . They differ in a short
stretchof 5' untranslated region (bp 1 to 49) andwithin the
coding and 3' untranslated region from by 569 to thevector
insertion site (numbering according to CD3rl in reference
14). pPink-2/71 and pPink-2/~plasmids were electroporated
into MA5.8 separately or together and transfectants selected
after 10-14 d in G418 .
Individual transfectantswere characterized by flow cytom-
etry for expression of theTCR using either the anti-CD3e
mAb 145.2C11 (2C11) (Fig . 2) or the anti-clonotypicantiTi
mAbA2B4.2 . Analyses were carried out on the original trans-
fectants or clones derived from the original transfectants .
Clones aredesignated by the number ofthe transfectant from
which they are derived followed by a decimal point and
number; since all transfectantsused were derivedfromMA5.8,
they were given the prefix "MA." The original transfectantsw
-C
2
Figure 1 .
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Expression constructs for transfection .cDNA encoding CD3tl
and CD3rwere subcloned into the pPink-2 vector asdescribed in Materials
and Methods . This places the insert under control of the SFFVLTR with
SV40 encoded poly(A) addition and splicing signals, the neomycin-resistance
gene and SV40 origin of replication . The solid bars within the inserts
indicate sequences common to CD3tf and CD3('. The dotted or hatched
bars represent sequence differences at the 5' and 3' ends of the inserts .
The 5' end of theCD3rinsert begins in thecommon sequences ofCD3f
and CD3tl. There are 49 by more on the 5' end of the CD3vl insert, in-
cluding 34 by of sequence unique to CD3tl and divergent from the 5'
end of C1331' (14) . The vector-encoded polyadenylation signal for the in-
sert is indicated by AAAA . The line outside of the inserts indicates the
coding region for CD3("or CD3rl . Plasmids were linearized with XmnI
before electroporation .
and clones both behaved identically in all assays. As shown
in Fig. 2 and consistent with prior observations, the MA5.8
mutant expresses 10-fold lessTCR than the parental cell line
2134.11 as judged by 2C11 reactivity. Transfection ofMA5.8
10 100 1 10 100 1000
Relative Fluorescence Intensity
Figure 2 .
￿
Flow cytometry analysis ofCD3Ti cell surface expression .
2B4.11, MA5.8, andMA5.8 transfiectants expressing C133 t, CD3rl or both
were stained with anti-CD3c mAb 2C11 (thick line) or controlmAb 11C5
(thin line) followed by FITC-conjugated goat anti-hamster antibody.
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with CD3~ resulted in surface TCR expression three to four-
fold greater than 2B4.11 asjudged by 2C11 reactivity . A similar
increase in reactivity was observed when transfectants were
analyzed with the anti-Ti mAb A2B4.2 (data not shown) .
The high level TCR expression observed for the CD3rtrans-
fectants was found in each of 15 transfectants examined. In
contrast, 43 of45 CD3rl transfectants examined showed little
anti-CD3c- mAb (see Fig . 2, MArl5.3) or antiTi MAb (data
not shown) reactivity above that observed for MA5.8 alone.
2 of45 CD3q transfectants, as represented byMAg61.9 and
MAg65.3, express significantly more TCR than the MA5 .8
cell line (Fig. 2) ; levels of expression are close to those of
2134.11 and threefold less than that of ~ transfectants . The
~-71 double transfectants and clones showed, perhaps not sur-
prisingly, a more heterogeneous level of TCR expression .
Northern Analysis of,'and r/ Transfectants.
￿
RNA was pre-
pared from representative transfectants, size fractionated by
agarose gel electrophoresis, transferred to nitrocellulosemem-
branes, and hybridized with a 11P labeled cDNA probe
specific forCD3q . Subsequently, the same blot was stripped
and rehybridized with a CD3' specific probe . As shown in
Fig. 3, the 1.7-kb CD3q mRNA is present in 2B4.11 but
absent inMA5.8 . In addition, a 3.4-kb band hybridizingwith
the CD3rl probe is detected in 2134.11 exclusively . The
significance of this species is presently unknown. The lanes
containing the RNA from CD3q transfectants MArl65 and
MA7161 lack the 1.7-kb endogenous CD3q mRNA but rather
demonstrate intense 2.9- and 2.2-kb hybridizing bands. The
latter represent Mil mRNA that are derived from the trans-
fected plasmid DNA . The unique sizes of these transcripts
Figure 3 .
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Expression ofCD3rand n mRNAs in 2B4 .11, MA5 .8, and
representative h 17, or r rlMA5.8 transfectants. 10 Fcg oftotal RNA iso-
lated from the indicated cells were size-fractionated on a 1% agarose gel
containing formaldehyde and transferred to nitrocellulose. The filter was
hybridized with a CD3tl-specific probe, washed, and exposed at -70°C
for 42 hwith an intensifying screen . The filter was then stripped, reprobed
with aCD3rspecific probe and exposed for 16 h . Positions of ribosomal
28S and 18S RNAs are indicated.are probably due to differences in transcriptional initiation
and/or termination sites of theDNA introduced intoMA-q65
and MAg61 via the pPink-2 vector ; both the insert and the
vector contain polyadenylation signals. MAr15.3 shown in Fig.
2 also expresses CD3r1 mRNA derived from transfectedcDNA
(data not shown) . In contrast and as expected, RNA from
the representative CD3~transfectant, NIA~43, lacks reactivity
with the CD3,q-specific probe. In ~-rl double transfectants,
MACr152 andMACr161, a weak but definite set ofhybridizing
bands identical in size to that found in the rl transfectants
are detected . Reanalysis of the same blot with aCD3rprobe
identified the 2-kb CD3~mRNA in 2B4.11 which is absent
in MA5.8 . The CD3~probe hybridized to twomRNA spe-
cies of 3.2- and 2.5-kb in ~ and r-7) transfectants but not
in,q transfectants . Again, endogenous and exogenous CD3~
mRNA bands could be readily detected in2B4.11 and trans-
fectants, respectively .
Given that the level of CD3r1 mRNA in i? transfectants
was as great or greater than the level of CD3~mRNA in
~ transfectants, the lower copy number of surfaceTCR com-
plexes on the q transfectants relative to ~ transfectants could
not be explained based simply on differences in steady-state
mRNA expression . Furthermore, in view of the observation
that syntheticRNA derived from CD3r1 and CD3~cDNA
clones translates equivalently in a wheat germ in vitro system
(data not shown), it is not obvious that translational differ-
ences account for the differential TCR surface expression in
these transfectants. The observed differences are clearly post-
transcriptionally regulated. It appears that CD3r1 is less able
than CD3y to facilitate surface TCR expression when trans-
fected into MA5.8 . This is also observed in 2B4.11 where
the levels ofmRNA for CD3~ and CD371 are very similar
(Fig . 3), while the level ofCD3,q protein associated with sur-
face TCR is an order of magnitude less than that of CD3~
(see below and reference 11) . We cannot exclude the possi-
bility that the steady-state level ofCM? protein is less than
CD3~ protein in the T cell.
Biochemical Analysis of 1LCR Isoforms in Transfectants.
￿
To
next characterize the TCR components in individual trans-
fectants, cells were surface labeled with 1251 by the lac-
toperoxidase method, solubilized in digitonin, and immu-
noprecipitated with anti-CD3e mAb. The resulting complex
was analyzed in a 2-D nonreducing/reducing gel . As shown
in the autoradiogram of 2B4.11 and as depicted schemati-
cally in Fig . 4 (bottom right panel), the offdiagonal Tict-(3
heterodimer at 40-60 kD and CD3y, CD36, and CD3e
subunits at 20, 25, and 26 kD, respectively, are readily ap-
parent . The CD3~-~ ~homodimer (16-kD subunits) and the
CD3~-t1 heterodimer (16- and 22-kD subunits) are evident
and the frequency of incorporation ofCD3~into the homo-
dimer is N10-fold greater than its incorporation into the
CD3~-ri heterodimer. A 26-kD spot below the diagonal in
2B4.11 represents the CD3e-e homodimer (l0a) . The CD3e-e
homodimer spot serves as an internal marker of the CD3~-rl
heterodimer, appearingjust above and to the left of the latter.
The set of offdiagonalCD3P spots to the right of theCD3~-P
homodimer likely represent CD3~ complexed to a smaller
set of -10-kD proteins . In addition, an 8-kD dimer run-
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ning at 16 kD in the nonreduced dimension is noted . The
significance ofthese spots is presentlyunknown but may rep-
resent other components of the TCR complex and/or in-
clude CD3~ degradation products .
In contrast to 2B4.11, the anti-CD3e immunoprecipitate
ofMA5.8 contains no CD3~or CD3r1 spots; only Tia-/3 and
CD3-y, CD36, andCD3e monomers and CD3e-e homodimer
spots are apparent . However, ~ transfectants ofMA5.8 such
asMAr43 have a readily detectableCD3~-~ ~homodimer spot
as well as CD3~ complexed to 10-kD structures. No CD3v1
is apparent in these cells, consistent with earlier studies
showing that CD3r1 is not a post-translationally modified
form ofCD3~ (26) . On the other hand, the representative
CD3r1 transfectant MAtl61 contains a homodimer appearing
as an offdiagonal spot at 22 kD in the reducing dimension,
directly below the CD3e-e homodimer, presumably repre-
enting CD3,q . No CD3~ is detected, again demonstrating
that CD3~ and CD3r1 are distinct proteins . Finally, the ~-q
Figure 4 .
￿
2-D gel analysis ofsurface-labeledTCR components on 2B4.11,
MA5.8, and representative transfectants . Cells were surface labeled with
1251 using lactoperoxidase, solubilized in digitonin and immunoprecipi-
tated with anti-CD3e mAb 2C11 . Immunoprecipitates were run on 2-D
nonreducing/reducing SDS-PAGE and autoradiographed . A schematic di-
agram (low right) depicts the positions of Tia, MO, CD3y, CD36, CD3e,
CD3y, and CD3r1 components. Note that while the 26-kD off-diagonal
spot is designated as a CD3e-e homodimer, we cannot exclude the possi-
bility that CD3e forms a heterodimer with unknown protein of the same
molecular weight (10a). Black arrowheads indicate the position of CD311
in the CD3e transfectant MAt161, the double transfectant MAj-r152 and
2B4.11. Theopen arrowheadsin theMArt152 double transfectant,MAf43,
and 2B4.11 indicate the position of CD31'. Molecular mass markers are
as follows : 97 kD, phosphorylase B ; 68 kD, BSA; 45 kD ovalbumin ; 31
kD, carbonic anhydrase ; 22 W, soybean trypsin inhibitor ; and 14 W,
lysozyme .double transfectantMAC-q52 contains both theCD3e ri het-
erodimer and the CD3~-r homodimer in the anti-CD3e
immunoprecipitate . The absence of the putative q-,q homo-
dimer in the double transfectants and relative abundance of
CD3eroverCD3~-q dimers implies that the preference for
subunit assembly in a stable TCR complex is CD3er >
CD3e ri > CD3q-ri . Note that while the surface TCR level
of MAr761 is equivalent to that of 2B4.11, the amount of
labeled CD3n protein in anti-CD3e immunoprecipitates of
MAr761 is much less than the total amount of CD3n plus
CD3q in immunoprecipitates of 2134.11, raising the possi-
bility that CD3rj is more loosely associated with the TCR
than CD3n.
Direct Identification ofthe CD3rj Gene Product in TCR Com-
plexes by Means of Specific .Antibody. To directly assess in-
dividual transfectants for the presence or absence of CD371
protein, we developed a rabbit antiserum, NS-2, against a
CD371-specific peptide for use in Western blot analysis of anti-
CD3e mAb immunoprecipitates from cells lysed in digitonin.
The antiserum NS-2 was produced against a synthetic pep-
tide corresponding to COOH-terminal amino acids 173-185
of CD3,q, which are not shared by CD3n (see Materials and
Methods) . As shown in Fig. 5 A, a specific 22-kD spot below
the diagonal is seen in lysates of the ovalbumin-specific,
I-Ad-restricted T cell hybridoma 3DO54.8 . This spot is not
present when the lysates were reacted with preimmune sera
from the same rabbit . Furthermore, while the CD3q spot
is also detected in 2B4.11 lysates, it is absent in the MA5.8
blot consistent with the lack of CD3,q mRNA in MA5.8.
These data prove the specificity of the anti-ij antiserum NS-2 .
The results ofexamination of transfectant lysates forCD3n
protein are shown in Fig. 5 B and demonstrate an expected
set ofpatterns . CD3n is present in the representative ~-ri trans-
fectant MAri752 and ri transfectants MA7161 and MAri65 .
In contrast, no NS-2 reactivity with the CD3,1 protein is
observed in the r transfectant MAr43 . Collectively, Northern
analysis, surface labeling and immunoprecipitation studies as
well as western blot analysis precisely delineate the differ-
ences in T cell receptor components of these transfectants :
-q transfectants express a TCR composed ofTine-flCD3yberi-7j,
r transfectants express aTCR composed ofTia-PCD3y&r-r
and r--q transfectants express bothTia-OCD3ybe~-r and Tioe-
OCD3y8e~-tI TCR complexes . In the latter case, we cannot
exclude the possibility that CD3n-~ andCD3~q dimers are
present within the same TCR complex .
Crosslinking ofTCR Isoforms Results in Signal Transduction
Leading to Cell Cycle Arrest. Having characterized individual
transfectant populations, it was important to assess the signal
transduction potential of their different TCR isoforms . To
this end, transfectants were stimulated in Immulon micro-
titer plates with or without anti-CD3e mAb . In additional
experiments, the TCR of transfectants was crosslinked with
I-Ek expressing LK35.2 cells pulsed with moth cytochrome
c peptide (KKANDLIAYLKQATK) which together define
the antigen/MHC specificity of the 2B4.11 TCR (18) . Ear-
lier analyses (27) demonstrated thatTCR crosslinking ofTT
hybridomas including 2B4.11 results in cell cycle arrest and
hence, a reduction in proliferation as measured by [3H]TdR
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Figure 5 .
￿
Westernblot analysis ofCD3rt expression in 3D054 .8, 2114 .11,
MA5 .8 (A), and representative transfectants (B) . Cells were lysed in
digitonin, immunoprecipitated with anti-CD3e mAb 2C11, and the
resulting immunoprecipitates were run on 2-D nonreducing/reducing SDS-
PAGE. Gels were blotted toPVDF membrane by electrophoretic transfer
and the filters were incubated with preimmune serum or anti-t1 polyclonal
antiserum NS-2 raised against a CD3+I peptide (see Materials and Methods) .
TheCD3n protein was detected using an alkaline phosphatase-conjugated
goat anti-rabbit antibody and Bio-Rad Laboratories alkaline phosphatase
developing reagents. Prestained molecular mass markers were ; 47 W, oval-
bumin; 33 W, carbonic anhydrase; 24 W, soybean trypsin inhibitor ; 16
kD, lysozyme. Arrowheads denote the position of the CD3r1 protein .
incorporation . Asshown in Table 1, TCR crosslinking with
anti-CD3e mAb resulted in a significant decrease in [3H]
TdR incorporation of 2B4.11 and all transfected lines . For
example, in comparison to media control, 2C11 reduced
[ 3H]TdR of MAr43.2 by up to 91% . Similar effects were
seen with all transfectants tested, regardless of their CD3n
or CD317 isotype . Only MA5.8 which expresses a low copynumber ofsurfaceTCR complexes and lacks CD3rand CD3rl
showed no effect . Similar results were obtained when the cells
were stimulated withantigen/MHC. The cytochrome c pep-
tide at 10-100 AM also significantly reduced [3H]TdR incor-
poration of2134.11 and all transfectants but was without sig-
nificant effect on the antigen unresponsiveMA5.8 line or the
TT hybridoma 313054.8 which has a different antigen
specificity .
To determine whether the basis for the cell cycle arrest medi-
ated by TCR crosslinking was the same or different in in-
dividual transfectants, representative cells were cultured in
plates in the presence or absence of anti-CD3e mAb for 24 h
and then cell cycle analysis performed by flow cytometry using
propidium iodide to stain the nuclear DNA. As shown in
Fig. 6, before TCR crosslinking, 284.11, MA5.8, MAf43,
MArt152, and MAg65 populations consisted of51-57% of
cells in G1, 33-38% in S and 5-15%, in G2/M . After TCR
crosslinking, all populations with the exception of MA5 .8
cells showed a reduction in cells in S phase (to 15-20%) . In
addition, the number of cells in G2/M was reduced (see Fig.
6) . These data indicate that TCRs comprising CD3ef,
CD3tl-n, or CD3Ptl transduce signals that arrest cell growth
at the Gt/S boundary of the cell cycle . Whether the lack of
cell cycle arrest in theMA5.8 cells is a result ofthe low number
Number in parentheses represents percent inhibition . Standard deviation was generally <10% .
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ofsurface TCRs being insufficient to trigger signals or results
from qualitative signaling differences due to the absence of
CD3r and CD3tl is not known at present .
Reversible Growth Inhibition Induced by Crosslinking of7CR
Isoforms. To examine the effects of TCR signal transduc-
tionon cell growth oftransfectants and the potential reversi-
bility of cell cycle arrest, an additional set of experiments was
performed . T cell hybridomas and transfectants were cultured
in the presence or absence ofanti-CD3e mAb and cell numbers
determined sequentially on each of 3 d in culture. In some
cases, cells were removed from 2C11 coated wells after 24 h
and replated into untreated wells . TCR crosslinking by 2C11
mAb resulted in growth arrest of2114.11 (Fig. 7) and 313054 .8
(data not shown), and this inhibitionwas irreversible . In con-
trast, the growth ofMA5.8 was unaffected by TCR cross-
linking. Importantly, r, tl or P- ,q transfectants also showed
growth arrest, but in each case, the growth inhibition was
reversible upon removal of the cells from the crosslinking
stimulus as shown in Fig . 7 (triangles) . Although not shown,
no transfectants lysed upon TCR stimulation, as judged by
"Cr release. Essentially the same results were obtained when
2134.11, MA5.8, and transfectants were stimulated with I-Ek-
expressing B10.BR splenocytes pulsed with the cytochrome
c peptide (data not shown) . These data show that neither
Table 1 .
￿
Growth Inhibition of Transfectants upon Stimulation with Antigen and MHC or Anti-Me mAb Crosslinking
Cells Peptide concentration : 0 AM
['H]TdR
1 1,M
incorporation
10 WM
cpm
100 AM
2B4.11 19,505 24,336 (0)' 19,042 (2 .4) 4,881 (74.4)
MA5 .8 102,430 112,516 (0) 99,479 (2 .9) 85,120 (16.8)
MA~43.2 96,531 74,353 (22.9) 54,580 (43.5) 10,151 (89.5)
MAP15.4 115,753 89,052 (23.1) 60,552 (47.7) 8,623 (92.6)
MAC 71 52.9 121,896 119,543 (1 .9) 106,256 (12.8) 59,530 (51.2)
MArrt 52.11 138,806 104,556 (24.7) 99,758 (28.1) 69,856 (49.7)
MA,q61.9 119,300 99,294 (16.8) 82,280 (31) 18,709 (84.3)
MA7165.3 114,335 103,377 (9.6) ND 71,275 (37.7)
313054 .8 69,738 54,872 (21) 69,544 (0) 69,290 (0)
Crosslinker : None Anti-CD3e
2134.11 10,476 2,141 (79.6)
MA5.8 57,331 56,853 (0.8)
MAP43.2 46,884 4,445 (90.5)
MAr15.4 51,432 8,369 (83 .7)
MAPil 52.9 23,217 14,154 (39)
MArt? 52.11 37.391 26,591 (28 .9)
MArt61 .9 55,561 29,604 (46.7)
MAt765.3 29,473 14,305 (51 .5)
313054 .8 32,021 1,441 (95.5)O
k
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CD3rl nor CD3", alone or in combination, is responsible
for irreversible cell cycle arrest in this system. Likewise, cross-
linking ofTCRs expressing CD3t1 does not mediate cell death
as assayed herein. The irreversible growth inhibition of2B4.11
cells afterTCR crosslinking is thus peculiar to T cell hybrid-
omas such as 2B4.11 and 3DO54.8 and not simply a conse-
quence of CD3q protein expression.
Discussion
In the present study,we have transfectedcDNAs encoding
CD3~or CD371 separately or together into the MA5.8 clonal
variant of the murine T-T hybridoma 2B4.11 . This clone is
an ideal recipient with which to study the role of the CD3'
and CD371 subunits sinceMA5.8 itself lacks both CD3~ and
3
2
0
2
2B4.11 MA5.8 X43 ~-r152
Fluorescence (DNA Content)
-161 .9
X43
1165.3
0 1 2 3 0 1 2 3 0 1 2 3
Days in Culture
Figure 7 .
￿
Effect ofTCR crosslinking oncell growth in 2B4.11,MA5 .8
and representative transfectants. Cells were plated at 2 x 10 4/well in plates
with (O) or without (" ) 2C11 mAb. Cell numbers were determined in
duplicate on days 1, 2, and 3 . To determine reversibility ofinhibition, samples
ofcells incubated for 24 h in 2C11-coated wells were collected and replated
into nontreated wells ; cell numbers were then determined on days 2 and
3 (A) .
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x165
Figure 6.
￿
Cell-cycle analysis ofthe effect ofTCR
crosslinking on 2B4 .11, MA5 .8, and representa-
tive transfectants . 2 x 105 cells were cultured for
24 h in ten wells of plates coated with (+, bottom
panels) or without (-, toppanels) anti-CD3emAb
2C11 . NuclearDNA was stained with 50,ug/ml
propidium iodide and analyzed forDNA content
by flow cytometry on aFACScan . Numbers in the
panels represent percentages of cells in G1, S, or
G2/M as shown in the top left panel for 2B4.11.
CD371mRNA but expresses the otherknownTCR compo-
nents, namelyCD3y, CD38, CD3e, Tict, and Tio subunits
(19) . The findings reported herein demonstrate that expres-
sion of CD3 " or CD3q mRNA under the control of the
SFFV LTR in stably transfected cell lines and clones results
in the production of protein subunits which form disulfide-
linked dimers that non-covalently associate with the other
TCR components. This association is shown in anti-CD3e
precipitates of digitonin lysates from transfected cells and by
the ability of the transfected subunits alone or together to
augment surface TCR expression as judged by quantitative
flow cytofluorometry. In q transfectants, the TCRassociated
CD3q component in anti-CD3e mAb immunoprecipitates
is present as a homodimer. Likewise, ~ transfectants express
a predominant TCR associatedCD3e~homodimer. In con-
trast, ~ - 11 double transfectants expressed both a CD3e ~
homodimer and a CD3
￿
11 heterodimer associated with the
TCR . The absence of a detectable CD3
￿
-1 heterodimer in
~ transfectants is consistent with the finding ofearlier studies
involving selective transfer ofCD3" into MA5.8 (28) and
our recent finding that CD3,q is an alternatively spliced product
of the common gene which encodes both CD3 ' andCD3q
proteins (14 ; Clayton, L .- K ., et al., manuscript submitted
for publication) . The lack of detectable TCR associated
CD3e-1? homodimers in the double transfectants implies that
the formation of this homodimer is least favored relative to
CD3
￿
~ and CD3
￿
q dimers .
Northern blot analysis of ~- -1 double transfectants indi-
cates that the level of steady-state CD3~andCD3q mRNA
is comparable in these cells . Nevertheless, the amount ofTCR
associated CD3 " protein in the CD3 71 heterodimers was
at least one order of magnitude less than the amount ofTCR
associated CD3 " protein in the CD3
￿
r homodimer. Given
that the extracellular segments ofCD3~and CD3q are iden-
tical, this disparity could not be readily explained on thebasis
of differential 1251 labeling of the two subunits . Rather, in
view of the fact that thecDNAs are driven by identical regula-
tory elements in the pPink-2 vector, the difference in the level
ofCD3 "andCD3q associatedwith theTCR must be post-
transcriptional.
Prior cytofluorometric analysis ofMA5.8 revealed that the
absence ofCD3' correlated with a marked decrease in cell
surface expression of the CD3Ti complex in this cell line
(19) . Restoration of CD3" biosynthesis upon transfection
reconstituted surface TCR expression . Furthermore, CD3'
G i : 57% 55 52 51 51
S : 38 34 33 34 35
5 11
~'
15 15 L
14
77 44 74 77 68
19 50 15 16 20 a s 11 7 11protein level as quantitated by immunoblotting correlated with
surfaceTCR expression (28) . Biosynthesis studies haveshown
that although the pentameric Ticx-OC133y8e structure is as-
sembled in the endoplasmic reticulum and transits into the
Golgi apparatus in the absence ofCD3~, the pentamers are
transported to the lysozomes where they are degraded (29,
30) . The increased surface TCR expression in T-T hybrid-
omas resulting from 11 transfection is N5-10-fold less than
the level resulting from ~ transfection . Even when the cells
express high levels ofCD3qmRNA as inMAg61.9, the level
of surface TCR is still three to fivefold less than in ~ transfec-
tants . It should be noted that 43 out of 45 71 transfectants
showedTCR expression as low asMA5.8 cells . For example,
the level ofTCR in MA-q5.3 is indistinguishable from that
of MÁ5.8 (Fig. 2), although this clone expresses CD3q
mRNA derived from the transfectedcDNA (data not shown) .
In contrast, all of the 15 rtransfectants tested expressed high
levels ofTCR . These results imply that either CD3q is less
efficient than CD3r in associating with the TCR pentamer
or, once associated, cannot salvage the complex from lysozomal
degradation as efficiently as CD3~ These possibilities are not
mutually exclusive. A short half-life ofCD3q protein and/or
the unique structural feature ofCD3,q could account for such
inefficiencies . Clearly, comparison of steady-state levels of
CD3r, and r proteins in transfectants will be informative.
Furthermore, if the physical association of the CD3rf-1i
homodimer with the TCR pentamer is weaker than that of
theCD3e~homodimer, then this may explain our inability
to detect the CD3rf-i7 receptor structure in immunoprecipi-
tates with anti-CD3e in cells expressing bothCD3~ andCM7
protein .
The present studies also have uncovered an additional com-
plexity within TCR components as evidenced in the ~ trans-
fectants. Anti-CD3e immunoprecipitates of 1251 surface-
labeled ~ transfectants identified all the known components
of the TCR heptamer, Tia-OCD3,yber~. In addition, a se-
ries of CD3r components linked to a heterogeneous set of
N10-kD proteins were detected . These heterodimeric forms
are also present in the parental 2134.11 TT hybridoma but
absent from MÁ5.8, consistent with the notion that the
10-kD structures bond specifically to CD3r. Although we
cannot exclude the possibility that some of theWAD spots
represent degradation products ofCD3r, in view of theCD3~
subunit's ability to complex either with itself or the related
CM7 subunit, the possibility thatCD3~could disulfide bond
to other molecules is likely. The recently identified structural
homology between the FcERly subunit and theCD3r subunit
(31, 32) raises the possibility thatFceRIy or a related protein
might comprise one subunit of these heterodimers . Alterna-
tively, the partner involved in heterodimeric formation might
be another structure. The identity of the 8-kD homodimer
in 2134.11 also must be determined . Clearly, further biochem-
ical analysis is required .
Crosslinking of surface TCRs on ~, 71, and r -i7 transfec-
tants with eitherCD3e mAb or a specific cytochrome c pep-
tide antigen and I-EkMHC restricting element expressed on
LK35 .2 cells or B10.BR splenocytes resulted in signaling in
each cell type, asjudged by cellular growth inhibition. Thus,
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in all cases, whenLK35.2 cells were pulsed with 10-100-,uM
concentrations of the cytochrome c peptide, [3H]TdR incor-
poration of those transfectants diminished substantially . Simi-
larly, exposure oftransfectants to anti-CD3e mAb-coated plates
resulted in reduced [3H]TdR incorporation . In contrast,
MÁ5.8 was unaffected by both types of crosslinking stimuli .
Cell-cycle analysis documented that this inhibition of
[3H]TdR incorporation was secondary to cycle arrest at the
G1/S boundary (Fig . 6) . This block was, however, reversible
since removal of transfectants from anti-CD3e mAb-coated
plates resulted in restoration of cell growth as shown in Fig.
7 . Thus, in no case did r, q or ~-tl transfectants die after
TCR triggering.
Mercep et al. have recently suggested the interesting possi-
bility that activation-driven programmed cell death is linked
to CD3e,q expression (13) . This hypothesis was based on
the observation that ~ transfectants ofMÁ5.8, lacking CD3~-ri
heterodimers, underwent little, it any, cell lysis and death upon
antigen/MHC or anti-CD3emAb crosslinking. In contrast,
the Mr-i1 expressing parental 2134.11 hybridoma was readily
killed . Unexpectedly, however, the present studies with 71
and ~-q transfectants clearly document that expression of
CD31?-tl homodimers without CD3et homodimers or
CD3e tJ heterodimers with CD3~-homodimers inMA5.8
cells does not lead to cell death . Consistent with results of
Ashwell et al . (27), however, we did observe death of the
CD3e-q expressing TT hybrrdomms, 2134.11 (Fig. 7) and
313054.8 (data not shown), upon anti-CD3e mAb cross-
linking. Collectively, the results imply that if the CD3?J
subunit is involved in providing a death signal after TCR
crosslinking, it, itself, is not sufficient to mediate programmed
cell death . Rather, since the MÁ5 .8 clonal variant was iso-
lated from 2134.11 cells by chemical mutagenesis, this line
may lack an important gene product required for the death
process .
The structural differences between CD3~ and CD371 are
such that theCM7 cytoplasmic domain lacks one ofsix poten-
tial tyrosine phosphorylation sites and a putative nucleotide
binding site (14) ; consequently, the signals emanating from
TCRs comprised ofTia-OCD3y6er, r, Tice-0CD3-y6e71-71,
and Tia-0CD3ybe~ t1 components are likely to be different .
It will be important to determine whether phosphoinositide
turnover, calcium mobilization, protein phosphorylation, and
induction of gene programs including that of ID2 produc-
tion are modulated in the same or different manner when
such receptors are crosslinked . In this regard, the reduced phos-
phoinositide turnover triggered by TCR crosslinking of
CD3~-r11- variants of 2134.11 and MÁ5.8 ~ transfectants
reported previously is consistent with this view (12, 13) .
The potential for expression of surface receptors with iden-
tical ligand specificities and different functional capabilities
is reminiscent of isotypy originally described for immuno-
globulin molecules. Given that the ratio ofCM7 to CD3 ~
mRNAs is at least as great in thymocytes as in splenic T
cells of neonatal and adult mice (Clayton, L . K . et al., manu-
script submitted for publication), CM7 containing receptors
are apparently important in thymic development . One can
imagine that theirexpression as eitherTCR associated CD3,q-,qhomodimers or CD3r,q heterodimers could be involved in
the selection process. For example, ifCD3q containing TCR
isotypes in conjunction with as yet unidentified other pro-
teins transmit a signal for programmed cell death, then
CD3,q-,q or CD3r 7) isotypes might regulate the negative se-
lection process . Restricted expression ofsuch isotypes within
the thymus would insure that TCR crosslinking in the pe-
ripheral lymphoid compartment does not result in cell death.
Perhaps additional heterogeneity in composition of subunits
yet to be defined also contributes to the signaling mecha-
nism in thymic selection.
Aside from putative differential signaling by theTCR struc-
tures, levels of surface TCR expression could be affected by
TCR isotypes and thereby influence the thymic selection pro-
cess . For instance, if a thymocyte expresses a relatively small
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